The Covid-19 pandemic triggered a significant rise in Spac investments in the healthtech sector. While Spacs offer opportunities for healthtech companies, the road to a de-Spac process can be complex and perilous.
► To learn more, visit our website – https://channels.ft.com/en/bigdeal/
► Watch more videos from this series here – https://www.youtube.com/playlist?list=PLrhpR40o4n5xDI-MtPqTLdS6KtCpoHP9s
► Check out our Community tab for more stories on the economy.
► Listen to our podcasts: https://www.ft.com/podcasts
► Follow us on Instagram: https://www.instagram.com/financialtimes